BRUIN CLL-321
BRUIN CLL-321: Phase III Trial of Pirtobrutinib vs Idelalisib + Rituximab or Bendamustine + Rituximab in Covalent BTK Inhibitor–Pretreated CLL/SLL

Released: December 11, 2024

Expiration: December 10, 2025

Activity

Progress
1
Course Completed